Haisco Pharmaceutical Group Co., Ltd. (002653.SZ)
CNY 42.8
(-0.23%)
CNY 42.8
(-0.23%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 6.65 Billion CNY | 10.04% |
| 2022 | 6.04 Billion CNY | 20.79% |
| 2021 | 5 Billion CNY | 0.17% |
| 2020 | 4.99 Billion CNY | -0.77% |
| 2019 | 5.03 Billion CNY | 15.33% |
| 2018 | 4.36 Billion CNY | 6.26% |
| 2017 | 4.1 Billion CNY | 10.62% |
| 2016 | 3.71 Billion CNY | 15.08% |
| 2015 | 3.22 Billion CNY | 12.27% |
| 2014 | 2.87 Billion CNY | 17.0% |
| 2013 | 2.45 Billion CNY | 26.25% |
| 2012 | 1.94 Billion CNY | 120.49% |
| 2011 | 882.7 Million CNY | 40.14% |
| 2010 | 629.88 Million CNY | 80.28% |
| 2009 | 349.39 Million CNY | -1.21% |
| 2008 | 353.68 Million CNY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q3 | 6.9 Billion CNY | 6.98% |
| 2024 Q1 | 6.84 Billion CNY | 2.85% |
| 2024 Q2 | 6.45 Billion CNY | -5.6% |
| 2023 Q1 | 6.47 Billion CNY | 7.17% |
| 2023 FY | 6.65 Billion CNY | 10.04% |
| 2023 Q4 | 6.65 Billion CNY | 7.08% |
| 2023 Q3 | 6.21 Billion CNY | -3.09% |
| 2023 Q2 | 6.41 Billion CNY | -1.05% |
| 2022 FY | 6.04 Billion CNY | 20.79% |
| 2022 Q4 | 6.04 Billion CNY | 8.89% |
| 2022 Q3 | 5.55 Billion CNY | -3.59% |
| 2022 Q2 | 5.75 Billion CNY | 11.69% |
| 2022 Q1 | 5.15 Billion CNY | 3.02% |
| 2021 Q3 | 4.86 Billion CNY | -1.35% |
| 2021 Q2 | 4.92 Billion CNY | -4.14% |
| 2021 FY | 5 Billion CNY | 0.17% |
| 2021 Q1 | 5.14 Billion CNY | 2.88% |
| 2021 Q4 | 5 Billion CNY | 2.97% |
| 2020 Q1 | 5.1 Billion CNY | 1.4% |
| 2020 Q2 | 5.31 Billion CNY | 4.02% |
| 2020 Q3 | 5.32 Billion CNY | 0.32% |
| 2020 Q4 | 4.99 Billion CNY | -6.22% |
| 2020 FY | 4.99 Billion CNY | -0.77% |
| 2019 Q1 | 4.37 Billion CNY | 0.1% |
| 2019 Q3 | 4.61 Billion CNY | 4.6% |
| 2019 Q4 | 5.03 Billion CNY | 9.0% |
| 2019 FY | 5.03 Billion CNY | 15.33% |
| 2019 Q2 | 4.41 Billion CNY | 1.05% |
| 2018 FY | 4.36 Billion CNY | 6.26% |
| 2018 Q1 | 4.21 Billion CNY | 2.59% |
| 2018 Q2 | 4.04 Billion CNY | -4.08% |
| 2018 Q3 | 3.73 Billion CNY | -7.61% |
| 2018 Q4 | 4.36 Billion CNY | 16.88% |
| 2017 Q4 | 4.1 Billion CNY | 6.29% |
| 2017 FY | 4.1 Billion CNY | 10.62% |
| 2017 Q3 | 3.86 Billion CNY | 1.95% |
| 2017 Q2 | 3.79 Billion CNY | 1.29% |
| 2017 Q1 | 3.74 Billion CNY | 0.78% |
| 2016 Q2 | 3.37 Billion CNY | 14.51% |
| 2016 FY | 3.71 Billion CNY | 15.08% |
| 2016 Q1 | 2.94 Billion CNY | -8.61% |
| 2016 Q4 | 3.71 Billion CNY | 8.83% |
| 2016 Q3 | 3.41 Billion CNY | 1.06% |
| 2015 Q2 | 2.8 Billion CNY | -4.36% |
| 2015 FY | 3.22 Billion CNY | 12.27% |
| 2015 Q4 | 3.22 Billion CNY | 15.11% |
| 2015 Q3 | 2.8 Billion CNY | 0.05% |
| 2015 Q1 | 2.93 Billion CNY | 1.93% |
| 2014 FY | 2.87 Billion CNY | 17.0% |
| 2014 Q3 | 2.66 Billion CNY | 8.29% |
| 2014 Q2 | 2.45 Billion CNY | 4.15% |
| 2014 Q1 | 2.36 Billion CNY | -3.89% |
| 2014 Q4 | 2.87 Billion CNY | 7.93% |
| 2013 Q3 | 2.23 Billion CNY | 16.18% |
| 2013 FY | 2.45 Billion CNY | 26.25% |
| 2013 Q4 | 2.45 Billion CNY | 10.14% |
| 2013 Q1 | 1.74 Billion CNY | -10.47% |
| 2013 Q2 | 1.92 Billion CNY | 10.2% |
| 2012 Q2 | 1.56 Billion CNY | 5.99% |
| 2012 Q3 | 1.74 Billion CNY | 11.57% |
| 2012 Q4 | 1.94 Billion CNY | 11.49% |
| 2012 FY | 1.94 Billion CNY | 120.49% |
| 2012 Q1 | 1.47 Billion CNY | 67.25% |
| 2011 FY | 882.7 Million CNY | 40.14% |
| 2011 Q2 | 709.66 Million CNY | 0.0% |
| 2011 Q3 | 757.13 Million CNY | 6.69% |
| 2011 Q4 | 882.7 Million CNY | 16.59% |
| 2010 FY | 629.88 Million CNY | 80.28% |
| 2010 Q4 | 629.88 Million CNY | 0.0% |
| 2009 FY | 349.39 Million CNY | -1.21% |
| 2008 FY | 353.68 Million CNY | 0.0% |